Long-Term Benefits of Composite Treatment Targe...

By HEOR Staff Writer

January 21, 2026

Sustained Composite Treatment Targets Enhance Clinical and Economic Outcomes in Type 2 Diabetes A recent modeling study examines the lon...
EU Medicine Authorizations 2025: A Milestone for Innovation and Accessibility
Obesity Medication Guidelines: Evidence-Based Approaches to Effective Treatment
Bausch Health’s Strategic Growth in Latin American Pharmaceuticals Thro...
2025 China Drug Catalog Boosts Access with 114 New Drugs and Innovative Solut...
Advancements in Continuous Glucose Monitoring for Type 2 Diabetes Management
Eloralintide Obesity Treatment: Phase 2 Trial Reveals Significant Weight Loss...
Navigating Novo Nordisk Board Changes: Leadership for Growth and Strategy
Sanofi Insulin Savings: Your Comprehensive Guide for 2025
Addressing GLP-1 Access Inequity: Lessons from HIV/AIDS Mobilization
Oral Semaglutide Benefits: EMA Approves First Oral GLP-1 RA with Cardiovascul...
Insights on GLP-1 Therapy in Bariatric Surgery Patients
Evolving Strategies in Type 2 Diabetes Management: NICE Guideline Update 2025